Franklin Street Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Franklin Street Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,050	Closed	-$38K	–	162
2019 Q3	$38K	Hold	2,050	–	–	﹤0.01%	154
2019 Q2	$54K	Hold	2,050	–	–	0.01%	154
2019 Q1	$53K	Hold	2,050	–	–	0.01%	154
2018 Q4	$47K	Hold	2,050	–	–	0.01%	143
2018 Q3	$66K	Sell	2,050 -50	-2%	-$1.5K	0.01%	156
2018 Q2	$59K	Buy	2,100 +100	+5%	+$3.56K	0.01%	156
2018 Q1	$71K	Hold	2,000	–	–	0.01%	160
2017 Q4	$78K	Hold	2,000	–	–	0.01%	162
2017 Q3	$51K	Hold	2,000	–	–	0.01%	154
2017 Q2	$55K	Hold	2,000	–	–	0.01%	147
2017 Q1	$66K	Hold	2,000	–	–	0.01%	154
2016 Q4	$48K	Hold	2,000	–	–	0.01%	168
2016 Q3	$73K	Hold	2,000	–	–	0.01%	176
2016 Q2	$45K	Hold	2,000	–	–	0.01%	198
2016 Q1	$42K	Hold	2,000	–	–	0.01%	221
2015 Q4	$61K	Hold	2,000	–	–	0.01%	222
2015 Q3	$49K	Hold	2,000	–	–	0.01%	223
2015 Q2	$64K	Hold	2,000	–	–	0.01%	222
2015 Q1	$71K	Sell	2,000 -5,000	-71%	-$137K	0.01%	206
2014 Q4	$159K	Sell	7,000 -10,000	-59%	-$202K	0.03%	196
2014 Q3	$330K	Hold	17,000	–	–	0.06%	185
2014 Q2	$618K	Buy	+17,000	New	+$578K	0.12%	151
2013 Q4	–	Sell	-1,350	Closed	-$49K	–	230
2013 Q3	$49K	Sell	1,350 -800	-37%	-$29.2K	0.01%	228
2013 Q2	$71K	Buy	+2,150	New	+$97.4K	0.02%	231

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franklin Street Advisors's RIGL Position: Q4 2019 in Review

Franklin Street Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 2,050 shares — an estimated $38K sold.

Franklin Street Advisors first reported a position in RIGL in Q2 2013 and held it in 24 quarters. The position peaked at $618K in Q2 2014. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

Franklin Street Advisors reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Franklin Street Advisors sold 2,050 Rigel Pharmaceuticals shares in Q4 2019, an estimated $38K.
Franklin Street Advisors first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 24 quarters.
Franklin Street Advisors's Rigel Pharmaceuticals position peaked at $618K in Q2 2014.
136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Franklin Street Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.